Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 09-2018 | 09-2017 | |
| Sales | 527,205 | 311,332 | 0 | 12,737 | 8,629 |
| Cost of Goods | 37,531 | 27,199 | N/A | 5,986 | 4,521 |
| Gross Profit | 489,674 | 284,133 | N/A | 6,751 | 4,108 |
| Operating Expenses | 541,970 | 402,757 | 0 | 296,540 | 170,790 |
| Operating Income | -51,765 | -118,425 | N/A | -288,803 | -166,161 |
| Interest Expense | 1,121 | 1,087 | 0 | 1,249 | 951 |
| Other Income | -2,160 | 110,309 | 0 | -1,318 | -4,379 |
| Pre-tax Income | -55,046 | -9,203 | 0 | -291,370 | -171,491 |
| Income Tax | 3,082 | -184 | N/A | 3,797 | -1,032 |
| Net Income Continuous | -58,128 | -9,019 | N/A | -295,167 | -170,459 |
| Net Income | $-58,128 | $-9,019 | $N/A | $-295,167 | $-170,459 |
| EPS Basic Total Ops | -1.86 | -0.29 | N/A | -10.56 | -6.72 |
| EPS Basic Continuous Ops | -1.86 | -0.29 | N/A | -10.61 | -6.69 |
| EPS Diluted Total Ops | -1.86 | -0.29 | N/A | -10.56 | -6.72 |
| EPS Diluted Continuous Ops | -1.86 | -0.29 | N/A | -10.61 | -6.69 |
| EPS Diluted Before Non-Recurring Items | -1.86 | -0.24 | -10.56 | N/A | N/A |
| EBITDA(a) | $-39,008 | $-109,185 | $N/A | $-279,513 | $-159,107 |